Z-2817-2015 Class III Terminated
FDA device recall Z-2817-2015 was initiated by Becton, Dickinson And Company, BD Biosciences on Aug 27, 2015 and is designated Class III. Reason for recall: CD4 FITC label contains an error in the Spanish small text - it states CD8 FITC. The recall status is terminated (terminated Aug 9, 2016). Affected quantity: 128 units.
Recall details
- Product Type
- Devices
- Report Date
- Sep 30, 2015
- Initiation Date
- Aug 27, 2015
- Termination Date
- Aug 9, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 128 units
Product description
CD4 (SK3), FITC; Contains CD4 FITC with gelatin and 0.1% sodium Azide. Catalog number 340133 in vitro diagnostic used in Hematology: The SK3 monoclonal antibody reacts with human CD4, a 59-kDa cell surface receptor expressed by a majority of thymocytes, a subpopulation of mature T helper cells, and at low levels on monocytes. CD4 is a receptor for the human immunodeficiency virus (HIV).
Reason for recall
CD4 FITC label contains an error in the Spanish small text - it states CD8 FITC.
Distribution pattern
Worldwide Distribution. US nationwide (TX, CA, NC, OH, SD, PA, CT, UT, MD, TX, GA), Argentina, Taiwan, Australia, Japan, China, New Zealand, Chile and Colombia.
Code information
Catalog Number 340133; lot # 5112711, Expiration date: 30 Nov 2016.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2817-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026